NEWSROOM

Get the latest Terumo Aortic news featuring our tailored thoracic,
thoracoabdominal and abdominal devices.

Terumo Aortic announces completion of enrolment of the Relay®Pro US Transection Pivotal Study

Terumo Aortic announced today the completion of enrolment of the Relay®Pro Traumatic Injury (Relay®Pro–T) Investigational Device Exemption (IDE) study in the United States. Relay®Pro is a low profile, next generation thoracic stent graft device designed to expand the treatment of thoracic endovascular aortic repair (TEVAR) to patients with smaller access vessels.

Terumo Aortic announces publication of the primary endpoint results from the TREO® Pivotal Study

Following recent approval by the US Food and Drug Administration (FDA) of the TREO® Abdominal Aortic Stent-Graft System for the treatment of patients with abdominal aortic aneurysms (AAA), Terumo Aortic announced today the publication of the primary endpoint results from the investigational device exemption (IDE) pivotal study in the Journal of Vascular Surgery.

Terumo Aortic Announces Mid-Term Results with Real-World use of the Relay®Plus Thoracic Stent Graft System

Following the recent publication in the Journal of Vascular Surgery, Terumo Aortic announced today the mid-term results from the Relay®Plus post approval study (PAS).


1 2 4 5

For more updates on Terumo Aortic, follow us on Twitter or LinkedIn.

MEDIA ENQUIRIES

Please reach out to our media relations contact for
press enquiries about our innovative solutions.


Carrie White
Head, Global Marketing Communications
+44 (0) 141 812 5555